Plasmolifting PRP Practice in Orthopedics
Platelet Rich Plasma, abbreviated PRP, is a fairly new promising direction in the treatment of a wide range of ophthalmic diseases.
The platelet-rich plasma of the patient's blood contains a significant amount of Alpha granules of human platelets, including bioactive molecules such as platelet growth factor, transforming factor, vascular endothelial factor, insulin-like growth factor and other biologically active substances.
When platelets or a drug with a platelet mass come into contact with damaged tissue, they are degranulated and trophic (growth) factors are released into the surrounding microenvironment. These biologically active substances interact with the cells of the damaged area and trigger a number of regenerative reactions, as well as potentiate the attraction of stem cells to the damaged area, which differentiate into cells of healthy tissue.
Learn more about the PRP Orthopedics Course
What happens with PRP therapy?
tissue regeneration accelerates;
inflammatory processes
decrease, pain syndrome decreases.
Indications for PRP therapy.
Dry eye syndrome as an additional therapy:
preclinical forms
clinical forms: filamentous keratitis, "dry" keratoconjunctivitis, recurrent corneal erosion, xerotic corneal ulcer, keratitis due to non-closure of the eye slit, scarring pemphigoid).
After layer-by-layer and through keratoplasty:
Primary corneal dystrophy (as auxiliary therapy).
Secondary corneal EED.
Post-traumatic eye conditions of varying severity.
Neurotrophic keratopathy:
Postinfectious, after infection caused by varicella-zoster or Herpes simplex viruses
Diabetic neuropathy.
Complication of the operation on the trigeminal nerve.
Abuse of local anesthetics.
Corneal ulcer of various etiologies in the subacute phase.
Infectious keratitis of various genesis in the subacute phase.
Some complications after refractive surgery.